High dose cytarabine (HiDAC) and mitoxantrone (MITO) is an effective induction therapy for high-risk acute myeloid leukemia (AML) Meeting Abstract
| Authors: | Larson, S.; Campbell, N.; Huo, D.; Artz, A.; Zhang, Y.; Gajria, D.; Green, M.; Rahimova, G.; Weiner, H.; Torres, M.; Odenike, O.; Godley, L. A.; Rich, E. S.; Thirman, M.; Larson, R. A.; Stock, W. |
| Abstract Title: | High dose cytarabine (HiDAC) and mitoxantrone (MITO) is an effective induction therapy for high-risk acute myeloid leukemia (AML) |
| Meeting Title: | 51st Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 114 |
| Issue: | 22 |
| Meeting Dates: | 2009 Dec 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2009-11-20 |
| Start Page: | 434 |
| Language: | English |
| ACCESSION: | WOS:000272725801228 |
| PROVIDER: | wos |
| PUBMED: | 22276299 |
| DOI: | 10.1182/blood.V114.22.1048.1048 |
| Notes: | Meeting Abstract: 1048 -- Source: Wos |
